Major MeSH terms read more often by clinicians | Frequency: clinician | Frequency: random | p-value | diff | Major MeSH terms occurring more often in a random sample | Frequency: clinician | Frequency: random | p-value | diff |
Pain/drug therapy | 0.0186 | 0.0010 | 0.0000 | 0.0176 | Polymorphism, Genetic | 0.0003 | 0.0042 | 0.0000 | −0.0038 |
Hip joint/surgery | 0.0154 | 0.0000 | 0.0000 | 0.0154 | DNA-Binding Proteins/metabolism | 0.0002 | 0.0037 | 0.0000 | −0.0035 |
Arthroscopy/methods | 0.0130 | 0.0002 | 0.0000 | 0.0129 | Models, Chemical | 0.0002 | 0.0035 | 0.0000 | −0.0033 |
Analgesics/opioids, therapeutic uses | 0.0135 | 0.0007 | 0.0000 | 0.0128 | Genetic Variation | 0.0008 | 0.0035 | 0.0012 | −0.0027 |
Meta-analysis as topic | 0.0122 | 0.0000 | 0.0000 | 0.0122 | Transcription Factors/metabolism | 0.0005 | 0.0032 | 0.0005 | −0.0027 |
Internet | 0.0133 | 0.0013 | 0.0000 | 0.0120 | Bacterial Proteins/metabolism | 0.0000 | 0.0027 | 0.0000 | −0.0027 |
Quality of life | 0.0133 | 0.0032 | 0.0000 | 0.0102 | Plant Extracts/pharmacology | 0.0003 | 0.0025 | 0.0012 | −0.0022 |
Physician–patient relationship | 0.0116 | 0.0017 | 0.0000 | 0.0099 | Enzyme Inhibitors/pharmacology | 0.0002 | 0.0023 | 0.0006 | −0.0022 |
Review literature as topic | 0.0098 | 0.0002 | 0.0000 | 0.0096 | DNA/chemistry | 0.0000 | 0.0022 | 0.0002 | −0.0022 |
Analgesics/opioids, adverse effects | 0.0087 | 0.0000 | 0.0000 | 0.0087 | Polymorphism, Genetic | 0.0003 | 0.0042 | 0.0000 | −0.0038 |
Minor MeSH terms read more often by clinicians | Frequency: clinician | Frequency: random | p-value | diff | Minor MeSH terms occurring more often in a random sample | Frequency: clinician | Frequency: random | p-value | diff |
Humans | 0.8608 | 0.6027 | 0.0000 | 0.2581 | Animals | 0.0754 | 0.2328 | 0.0000 | −0.1574 |
Adult | 0.2979 | 0.1625 | 0.0000 | 0.1354 | Mice | 0.0182 | 0.0675 | 0.0000 | −0.0493 |
Female | 0.4321 | 0.3025 | 0.0000 | 0.1296 | Rats | 0.0141 | 0.0458 | 0.0000 | −0.0317 |
Male | 0.4216 | 0.2937 | 0.0000 | 0.1280 | Molecular sequence data | 0.0035 | 0.0312 | 0.0000 | −0.0276 |
Middle aged | 0.2692 | 0.1490 | 0.0000 | 0.1202 | Cell line | 0.0031 | 0.0220 | 0.0000 | −0.0189 |
Aged | 0.1868 | 0.1040 | 0.0000 | 0.0828 | Amino acid sequence | 0.0014 | 0.0193 | 0.0000 | −0.0179 |
Treatment outcome | 0.0989 | 0.0515 | 0.0000 | 0.0474 | Cells, cultured | 0.0048 | 0.0217 | 0.0000 | −0.0168 |
Adolescent | 0.1100 | 0.0690 | 0.0000 | 0.0410 | Base sequence | 0.0031 | 0.0185 | 0.0000 | −0.0154 |
Elderly: 80 and over | 0.0722 | 0.0388 | 0.0000 | 0.0333 | Cell line, tumor | 0.0034 | 0.0170 | 0.0000 | −0.0136 |
Prospective studies | 0.0548 | 0.0240 | 0.0000 | 0.0308 | Kinetics | 0.0016 | 0.0152 | 0.0000 | −0.0136 |